These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 25033434)

  • 1. Surface engineered nanostructured lipid carriers for efficient nose to brain delivery of ondansetron HCl using Delonix regia gum as a natural mucoadhesive polymer.
    Devkar TB; Tekade AR; Khandelwal KR
    Colloids Surf B Biointerfaces; 2014 Oct; 122():143-150. PubMed ID: 25033434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
    Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
    Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties.
    Duong VA; Nguyen TT; Maeng HJ; Chi SC
    Pharm Res; 2019 Jul; 36(10):138. PubMed ID: 31350675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles of ondansetron HCl for intranasal delivery: development, optimization and evaluation.
    Joshi AS; Patel HS; Belgamwar VS; Agrawal A; Tekade AR
    J Mater Sci Mater Med; 2012 Sep; 23(9):2163-75. PubMed ID: 22802103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics.
    Wavikar P; Pai R; Vavia P
    J Pharm Sci; 2017 Dec; 106(12):3613-3622. PubMed ID: 28923321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agranulocytosis-Protective Olanzapine-Loaded Nanostructured Lipid Carriers Engineered for CNS Delivery: Optimization and Hematological Toxicity Studies.
    Gadhave DG; Tagalpallewar AA; Kokare CR
    AAPS PharmSciTech; 2019 Jan; 20(1):22. PubMed ID: 30604305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery.
    Wavikar PR; Vavia PR
    J Liposome Res; 2015; 25(2):141-9. PubMed ID: 25203610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucoadhesive nanostructured lipid carriers (NLCs) as potential carriers for improving oral delivery of curcumin.
    Chanburee S; Tiyaboonchai W
    Drug Dev Ind Pharm; 2017 Mar; 43(3):432-440. PubMed ID: 27808665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation.
    Zafar A; Awad Alsaidan O; Alruwaili NK; Sarim Imam S; Yasir M; Saad Alharbi K; Singh L; Muqtader Ahmed M
    Int J Pharm; 2022 Nov; 627():122232. PubMed ID: 36155794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal administration of ondansetron using a novel microspheres delivery system.
    Mahajan HS; Gattani SG
    Pharm Dev Technol; 2009; 14(2):226-32. PubMed ID: 19519195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule.
    Salem LH; El-Feky GS; Fahmy RH; El Gazayerly ON; Abdelbary A
    J Pharm Sci; 2020 Jul; 109(7):2237-2251. PubMed ID: 32320670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability enhancement of ondansetron after nasal administration of Caesalpinia pulcherrima-based microspheres.
    Suryawanshi SR; Thakare NP; More DP; Thombre NA
    Drug Deliv; 2015; 22(7):894-902. PubMed ID: 24279581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and Characterization of Nanostructured Lipid Carriers of Rizatriptan Benzoate-Loaded
    Mathure D; Ranpise H; Awasthi R; Pawar A
    Assay Drug Dev Technol; 2022 Jul; 20(5):211-224. PubMed ID: 35771865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy.
    Alam T; Pandit J; Vohora D; Aqil M; Ali A; Sultana Y
    Expert Opin Drug Deliv; 2015 Feb; 12(2):181-94. PubMed ID: 25164097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nose to Brain Delivery of Astaxanthin-Loaded Nanostructured Lipid Carriers in Rat Model of Alzheimer's Disease: Preparation, in vitro and in vivo Evaluation.
    Shehata MK; Ismail AA; Kamel MA
    Int J Nanomedicine; 2023; 18():1631-1658. PubMed ID: 37020692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
    Ammar HO; Mohamed MI; Tadros MI; Fouly AA
    AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG; Mahajan HS
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.
    Pokharkar V; Patil-Gadhe A; Palla P
    Biomed Pharmacother; 2017 Oct; 94():150-164. PubMed ID: 28759752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-Protected thiolated nanostructured lipid carriers exhibiting improved mucoadhesive properties.
    Arshad S; Masood-Ur-Rehman ; Hussain Asim M; Nazir I; Shahzadi I; Mousli M; Bernkop-Schnürch A
    Int J Pharm; 2020 Sep; 587():119690. PubMed ID: 32738459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.